Publications by authors named "Bruce Montgomery"

100Publications

The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.

Fed Pract 2020 Aug;37(Suppl 4):S48-S53

is an Oncologist and is Network Director at VA Puget Sound Health Care System in Seattle, Washington. is an Oncologist at the Greater Los Angeles Health Care System and a Professor of Medicine at the University of California, Los Angeles. is Program Director, Million Veteran Program. is Scientific Program Manager of Oncology and is Chief Research and Development Officer, all in the Office of Research and Development, Veterans Health Administration. Bruce Montgomery is a Professor of Medicine at the University of Washington in Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/fp.0021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473728PMC
August 2020

Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment.

J Clin Oncol 2020 Nov 8;38(32):3740-3742. Epub 2020 Sep 8.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01755DOI Listing
November 2020

Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.

Cell Rep 2020 May;31(8):107669

Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Urology, University of Washington, Seattle, WA 98195, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.107669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453577PMC
May 2020

Revealing Metabolic Liabilities of Ralaniten To Enhance Novel Androgen Receptor Targeted Therapies.

ACS Pharmacol Transl Sci 2019 Dec 26;2(6):453-467. Epub 2019 Sep 26.

Department of Genome Sciences Centre, BC Cancer Research Centre, 675 W 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsptsci.9b00065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088963PMC
December 2019

Prostate cancer in military veterans.

Authors:
Bruce Montgomery

Clin Adv Hematol Oncol 2019 Oct;17(10):552-554

University of Washington, Fred Hutchinson Cancer Research Center, VA Puget Sound Health Care System, Seattle, Washington.

View Article

Download full-text PDF

Source
October 2019

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.

Eur Urol 2020 03 20;77(3):333-341. Epub 2019 Oct 20.

Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.09.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365609PMC
March 2020

Clinical Acumen Versus Androgen Receptor Variant 7 Circulating Tumor Cells in Decision-Making for Men with Advanced Prostate Cancer.

Eur Urol 2020 02 13;77(2):178-179. Epub 2019 Oct 13.

VA Puget Sound, Seattle, WA, USA; University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.09.028DOI Listing
February 2020

VHA Practice Guideline Recommendations for Diffuse Gliomas.

Fed Pract 2018 Aug;35(Suppl 5):S28-S35

is the Acting Chief of Pathology and Laboratory Medicine Service at VA Pittsburgh Healthcare System and member of the Division of Neuropathology at University of Pittsburgh Department of Pathology, is an Otolaryngologist at VA Pittsburgh Healthcare System, and is the Section Chief of Hematology\Oncology at VA Pittsburgh Healthcare System in Pennsylvania. is an Oncologist at VA-New York Harbor Healthcare System. is a Pathologist at University of Pittsburgh Department of Pathology in Pennsylvania. is Chief of Pathology and Laboratory Medicine Services at the South Texas Veterans Healthcare System in San Antonio. is the former Chief of Pathology and Laboratory Medicine Service at VA Pittsburgh Healthcare System. is a Pathologist at St. Louis VA Medical Center in Missouri. is the VA National Director of Pathology and Laboratory Medicine Services. is a Pathologist at Bay Pine Health Care System in Florida. is an Investigator at VA Salt Lake Health Care System Informatics and Computing Infrastructure. is an Oncologist at VA Puget Sound Health Care System, in Seattle, Washington. is the Director of Genomic Medicine Implementation and Associate Director of Genomic Medicine for the VA. is a Neuro-Oncologist at George E. Wahlen VA Medical Center and the Director of Medical Neuro-Oncology at the Huntsman Cancer Institute, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248149PMC
August 2018

AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?

Clin Cancer Res 2019 03 27;25(6):1696-1698. Epub 2018 Dec 27.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-3727DOI Listing
March 2019

Downregulation of Accelerates Progression to Castration-Resistant Prostate Cancer.

Cancer Res 2018 11 21;78(22):6354-6362. Epub 2018 Sep 21.

Department of Medicine and Cancer Center, Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-0687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239953PMC
November 2018

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.

Cell 2018 06;173(7):1770-1782.e14

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.04.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084431PMC
June 2018

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.

Urol Oncol 2018 07 12;36(7):342.e7-342.e14. Epub 2018 Apr 12.

Department of Urology, University of Washington School of Medicine, Seattle, WA; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau (SAR), China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183009
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.03.016DOI Listing
July 2018

Adjuvant Chemotherapy for Prostate Cancer: The Long and Winding Road.

Eur Urol 2018 06 9;73(6):877-878. Epub 2018 Mar 9.

University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.02.021DOI Listing
June 2018

Polyclonal Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate Cancer.

JCO Precis Oncol 2018 14;2. Epub 2018 Feb 14.

All authors, University of Washington; and , Fred Hutchinson Cancer Research Center; and , Veterans Affairs Puget Sound Health Care System, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446371PMC
February 2018

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

J Clin Oncol 2018 04 20;36(10):991-999. Epub 2017 Dec 20.

Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University; Walter M. Stadler, University of Chicago, Chicago; Daniel H. Shevrin, NorthShore University Health System, Evanston, IL; Maha Hussain, Stephanie Daignault-Newton, Lakshmi P. Kunju, Javed Siddiqui, Yi-Mi Wu, Dan Robinson, Robert J. Lonigro, Xuhong Cao, Scott A. Tomlins, Rohit Mehra, David C. Smith, Megan V. Caram, and Arul M. Chinnaiyan, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Przemyslaw W. Twardowski, City of Hope Cancer Center, Duarte; Felix Y. Feng, University of California San Francisco, San Francisco, CA; Costantine Albany, Simon Cancer Center, Indiana University, Indianapolis, IN; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Kathleen A. Cooney, University of Utah, Salt Lake City, UT; Bruce Montgomery, University of Washington, Seattle, WA; Emmanuel S. Antonarakis, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Paul G. Corn, University of Texas MD Anderson Cancer Center, Houston, TX; Young E. Whang, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; and Karen E. Knudsen, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075827PMC
April 2018

Prostate Cancer Screening in a New Era of Genetics.

Clin Genitourin Cancer 2017 12 31;15(6):625-628. Epub 2017 May 31.

Department of Medicine, University of Washington, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.05.024DOI Listing
December 2017

Testicular vs adrenal sources of hydroxy-androgens in prostate cancer.

Endocr Relat Cancer 2017 08 29;24(8):393-404. Epub 2017 Jun 29.

Department of Systems Pharmacology & Translational TherapeuticsPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593253PMC
August 2017

Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit".

Int Braz J Urol 2017 Mar-Apr;43(2):230-238

Frimley Park Foundation Trust, United Kingdom.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433361PMC
http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145DOI Listing
August 2017

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma.

Indian J Urol 2017 Jan-Mar;33(1):76-78

Targeted Cancer Therapy, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7WG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0970-1591.194787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264200PMC
February 2017

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

N Engl J Med 2016 Aug 6;375(5):443-53. Epub 2016 Jul 6.

From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986616PMC
August 2016

Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer.

Med Oncol 2016 Jul 14;33(7):77. Epub 2016 Jun 14.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-016-0793-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298886PMC
July 2016

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.

Eur Urol 2016 06 24;69(6):992-5. Epub 2015 Dec 24.

Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909531PMC
June 2016

In Reply to Bhattacharyya et al.

Int J Radiat Oncol Biol Phys 2015 Nov;93(3):719-20

University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.06.026DOI Listing
November 2015

Mucin Binding Reduces Colistin Antimicrobial Activity.

Antimicrob Agents Chemother 2015 Oct 13;59(10):5925-31. Epub 2015 Jul 13.

Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00808-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576126PMC
October 2015

Integrative clinical genomics of advanced prostate cancer.

Cell 2015 May;161(5):1215-1228

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484602PMC
May 2015

Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report.

Clin Genitourin Cancer 2015 Aug 31;13(4):e325-e328. Epub 2014 Dec 31.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563804PMC
August 2015

The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.

Chem Biol Interact 2015 Jun 13;234:332-8. Epub 2014 Dec 13.

Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00092797140039
Publisher Site
http://dx.doi.org/10.1016/j.cbi.2014.12.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414681PMC
June 2015

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.

PLoS One 2014 30;9(10):e111545. Epub 2014 Oct 30.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111545PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214744PMC
December 2015

Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.

Thorax 2015 Jan 16;70(1):12-20. Epub 2014 Oct 16.

Department of Medicine, Division of Pulmonary and Critical Care, Oregon Health & Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2014-205918DOI Listing
January 2015

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

J Clin Oncol 2014 Nov 13;32(33):3705-15. Epub 2014 Oct 13.

Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.4578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226804PMC
November 2014

Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.

Endocrinology 2014 Nov 22;155(11):4124-32. Epub 2014 Aug 22.

School of Medicine (E.C., R.B.M.), University of Washington, Seattle, Washington 98195; and Division of Clinical Research (E.A.M.), Fred Hutchinson Cancer Research Center, Seattle, Washington 98109.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2014-1337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298565PMC
November 2014

The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.

Cancer Discov 2014 Nov 13;4(11):1310-25. Epub 2014 Aug 13.

Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Pathology, University of Washington, Seattle, Washington. Department of Urology, University of Washington, Seattle, Washington. Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-13-1010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409786PMC
November 2014

Glucocorticoids and prostate cancer treatment: friend or foe?

Asian J Androl 2014 May-Jun;16(3):354-8

Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.125392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023359PMC
December 2014

Targeted androgen pathway suppression in localized prostate cancer: a pilot study.

J Clin Oncol 2014 Jan 9;32(3):229-37. Epub 2013 Dec 9.

Elahe A. Mostaghel, Rachel Hunter Merrill, and Roman Gulati, Fred Hutchinson Cancer Research Center; Elahe A. Mostaghel, Peter S. Nelson, Paul Lange, Daniel W. Lin, William Ellis, Robert Vessella, and Bruce Montgomery, University of Washington; Brett Marck, Alvin M. Matsumoto, and Lawrence D. True, Veterans Affairs Puget Sound Health Care System, Seattle, WA; Mary Ellen Taplin and Philip Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Steven Balk, Beth Israel Deaconess Medical Center, Boston, MA; and Daniel Tamae and Trevor Penning, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/12/09/JCO.2012.48
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.48.6431
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.6431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887479PMC
January 2014

Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit.

Clin Cancer Res 2014 Feb 4;20(4):791-8. Epub 2013 Dec 4.

Authors' Affiliations: Division of Clinical Research, Fred Hutchinson Cancer Research Center; and Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944407PMC
February 2014

Purinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions.

Am J Physiol Renal Physiol 2014 Feb 27;306(3):F286-98. Epub 2013 Nov 27.

Dept. of Biochemistry and Physiology, Faculty of Health and Medical Science, Univ. of Surrey, Guildford, Surrey GU2 7XH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00291.2013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920053PMC
February 2014

Aerosolized antibiotics: do they add to the treatment of pneumonia?

Curr Opin Infect Dis 2013 Dec;26(6):538-44

aVirginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine, Washington University School of Medicine, St. Louis, Missouri bVirginia Commonwealth University School of Pharmacy, Richmond cPrincipal, Hamilton House, Virginia Beach, Virginia dCardeas Pharma Corp., Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QCO.0000000000000004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814630PMC
December 2013

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

J Cyst Fibros 2013 Mar 15;12(2):130-40. Epub 2012 Sep 15.

Baylor College of Medicine, Pediatric Pulmonology, TCH Clinical Care Center, 6701 Fannin, Suite 1040.12, Houston, Texas 77030-2399, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2012.07.006DOI Listing
March 2013

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.

PLoS One 2012 18;7(1):e30062. Epub 2012 Jan 18.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030062PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261168PMC
July 2012

Replacing the suprapubic catheter that has 'fallen out'.

Ann R Coll Surg Engl 2011 May;93(4):322

Department of Urology, Frimley Park Hospital, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1308/003588411x570909bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363088PMC
May 2011